Search

The use of artificial intelligence (AI) to create works of art creates interesting legal challenges to the protection of intellectual property. A copyright infringement class action lawsuit has been filed against providers of AI software that is used to generate visual works of art based on...

Lukas Pfannenstiel was invited to speak at the US Summit of Laboratory Medicine Innovations conference on January 13th in Houston, TX. The title of his session was "How to Protect Intellectual Property in IVD Research and Development" and focused on the basics of patent protection for academic...

Demystifying International & Interstate Discovery Bill Baton, Vice Chair of the firm's Intellectual Property Practice , will moderate a panel presented by The United States District Court for the District of New Jersey, in conjunction with the Association of the Federal Bar of New Jersey. This...

​On November 4, 2022, the Supreme Court granted certiorari in Amgen v. Sanofi, No. 21-757, agreeing to review, “whether enablement is governed by the statutory requirement that the specification teach those skilled in the art to ‘make and use’ the claimed invention, 35 U.S.C. § 112, or whether it...

Associate Tom Laser will present during the semi-monthly meeting of the Chicago Bar Association's Consumer Finance Committee. The topic will be the 5th Circuit Court of Appeals' recent decision declaring that the Consumer Financial Protection Bureau's funding structure is unconstitutional.

The use of artificial intelligence (AI) to create works of art and inventions raises interesting legal challenges to the protection of intellectual property (IP). The plain language of the Copyright Act and Patent Act present obstacles to inventors and artists who may use or be AI systems. Recent...

The CFPB Funding Is Under Constitutional Attack. Does the Bureau Survive? Francis "Trip" Riley, Co-Chair of the firm's Consumer Financial Services Litigation Practice, will participate as a speaker during an upcoming RESPRO webinar. This webinar will look at the history leading up to the Community...

Kathryn Doyle, a partner at Saul Ewing, will present during the Penn Medicine Commercialization Speaker Series. She will discuss the latest trends in Life Sciences intellectual property on November 17 from 12:00 - 1:00 p.m.

Saul Ewing attorneys hosted this fast-paced webinar, providing a list of things you need to know to develop your checklist for legal issues in 2023, from employment, corporate governance, cybersecurity and privacy, intellectual property to tax. Attorneys with specialized knowledge in these areas...

Evolution of Cyber Insurance and the Impact on Cyber and Privacy Risk Management Laurie Kamaiko will speak at the Privacy + Security Forum 2022. Her panel is entitled "Evolution of Cyber Insurance and The Impact on Cyber and Privacy Risk Management." More details to come.

Jury selection begins in tax fraud trial against Trump Organization l ABCNL The Trump Organization has pleaded not guilty to the criminal tax fraud charges and the former president has dismissed the investigation as a "hoax."

Darius Gambino with Danny Cevallos - on Andy Warhol/Prince SCOTUS Case and Copyright Law in Art Danny Cevallos guest hosts the Michael Smerconish Program where he invites Saul Ewing's Darius Gambino to talk copyright law in art and music. Original air date, 14 October 2022.

The Consumer Financial Protection Bureau (“CFPB”) is grappling with determining the most effective means of regulating the buy now pay later industry. BNPL allows a consumer to obtain a product or services immediately at the time of purchase and to make installment payments on the purchase over time...

“Penny wise but pound foolish” first appeared in writing over 500 years ago. This idiom captures the wisdom of human experience in just five words: shortcuts that appear to save money are more expensive in the long run. Sometimes much more. Further proof of this eternal truth - and one taxpayer’s...

Charles M. Lizza and Sarah A. Sullivan of Saul Ewing’s Newark Office secured a precedent-setting victory in a patent infringement case in the Federal District Court for the District of New Jersey involving Janssen Pharmaceuticals, Inc.’s (“J&J”) and Mitsubishi Tanabe Pharma Corp.’s (“MTPC”)...